{"schema_version":"secwatch.filing_event.v1","accession":"0000818479-25-000018","form_type":"8-K","ticker":"XRAY","cik":"0000818479","company_name":"DENTSPLY SIRONA Inc.","filed_at":"2025-02-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:06.427232+00:00","generated_at":"2026-05-26T23:40:31.937450+00:00","sec_items":["7.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Dentsply Sirona starts strategic review for Wellspect Healthcare unit","bullets":["Wellspect provides bladder/bowel care products (LoFric, Navina); $2B TAM.","Mid-to-high single-digit organic sales growth in 2023 and first 3Q of 2024.","Goldman Sachs & Co. LLC (financial) and Wachtell Lipton (legal) retained as advisors.","No deadline or assurance that a transaction will result from the review.","Q4 & full-year 2024 results to be reported on February 27, 2025 as planned."],"urls":{"canonical":"https://secwatch.observer/filing/0000818479-25-000018","json":"https://secwatch.observer/filing/0000818479-25-000018.json","markdown":"https://secwatch.observer/filing/0000818479-25-000018.md","text":"https://secwatch.observer/filing/0000818479-25-000018.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/818479/000081847925000018/0000818479-25-000018-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/818479/000081847925000018/xray-20250211.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T23:40:31.937450+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}